Glucagon-Like Peptide-1 Receptor Agonist Protects Dorsal Root Ganglion Neurons against Oxidative Insult
Open Access
- 21 February 2019
- journal article
- research article
- Published by Wiley in Journal of Diabetes Research
- Vol. 2019, 1-10
Abstract
Objective. Diabetic polyneuropathy (DPN) is one of the most prevalent diabetic complications. We previously demonstrated that exendin-4 (Ex4), a glucagon-like peptide-1 receptor agonist (GLP-1RA), has beneficial effects in animal models of DPN. We hypothesized that GLP-1 signaling would protect neurons of the peripheral nervous system from oxidative insult in DPN. Here, the therapeutic potential of GLP-1RAs on DPN was investigated in depth using the cellular oxidative insult model applied to the dorsal root ganglion (DRG) neuronal cell line. Research Design and Methods. Immortalized DRG neuronal 50B11 cells were cultured with and without hydrogen peroxide in the presence or absence of Ex4 or GLP-1(7-37). Cytotoxicity and viability were determined using a lactate dehydrogenase assay and MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt), respectively. Antioxidant enzyme activity was evaluated using a superoxide dismutase assay. Alteration of neuronal characteristics of 50B11 cells induced by GLP-1RAs was evaluated with immunocytochemistry utilizing antibodies for transient receptor potential vanilloid subfamily member 1, substance P, and calcitonin gene-related peptide. Cell proliferation and apoptosis were also examined by ethynyl deoxyuridine incorporation assay and APOPercentage dye, respectively. The neurite projection ratio induced by treatment with GLP-1RAs was counted. Intracellular activation of adenylate cyclase/cyclic adenosine monophosphate (cAMP) signaling was also quantified after treatment with GLP-1RAs. Results. Neither Ex4 nor GLP-1(7-37) demonstrated cytotoxicity in the cells. An MTS assay revealed that GLP-1RAs amended impaired cell viability induced by oxidative insult in 50B11 cells. GLP-1RAs activated superoxide dismutase. GLP-1RAs induced no alteration of the distribution pattern in neuronal markers. Ex4 rescued the cells from oxidative insult-induced apoptosis. GLP-1RAs suppressed proliferation and promoted neurite projections. No GLP-1RAs induced an accumulation of cAMP. Conclusions. Our findings indicate that GLP-1RAs have neuroprotective potential which is achieved by their direct actions on DRG neurons. Beneficial effects of GLP-1RAs on DPN could be related to these direct actions on DRG neurons.Keywords
Funding Information
- Aichi Medical University Aikeikai (15H06720)
- Japan Diabetes Foundation (15H06720)
- Manpei Suzuki Diabetes Foundation (15H06720)
- Japan Association for Diabetes Education and Care (15H06720)
- Ministry of Education, Culture, Sports, Science and Technology (15H06720)
This publication has 48 references indexed in Scilit:
- Glucagon-like peptide-1 (GLP-1) action in the mouse area postrema neuronsPeptides, 2018
- Liraglutide regulates the viability of pancreatic α-cells and pancreatic β-cells through cAMP-PKA signal pathwayLife Sciences, 2018
- Regulation of glucagon‐like peptide‐1 sensitivity by gut microbiota dysbiosisJournal of Diabetes Investigation, 2017
- Incretin concept revised: The origin of the insulinotropic function of glucagon‐like peptide‐1 – the gut, the islets or both?Journal of Diabetes Investigation, 2017
- Sensory Neurons that Detect Stretch and Nutrients in the Digestive SystemCell, 2016
- Sensory and motor physiological functions are impaired in gastric inhibitory polypeptide receptor‐deficient miceJournal of Diabetes Investigation, 2013
- The Diabetic Neuropathies: Practical and Rational TherapySeminars in Neurology, 2012
- Exendin-4 Ameliorates Motor Neuron Degeneration in Cellular and Animal Models of Amyotrophic Lateral SclerosisPLOS ONE, 2012
- Insights from The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study on The Use of Intensive Glycemic Treatment to Reduce The Risk of Complications of Type 1 DiabetesEndocrine Practice, 2006
- Cyclic AMP Induces Transactivation of the Receptors for Epidermal Growth Factor and Nerve Growth Factor, Thereby Modulating Activation of MAP Kinase, Akt, and Neurite Outgrowth in PC12 CellsJournal of Biological Chemistry, 2002